Effect of a comprehensive programme to provide universal access to care for sputum-smear-positive multidrug-resistant tuberculosis in China: a before-and-after study

• Main Authors: Renzhong Li, MS (Author), Yunzhou Ruan, PhD (Author), Qiang Sun, PhD (Author), Xiexiu Wang, MS (Author), Mingting Chen, MS (Author), Hui Zhang, PhD (Author), Yanlin Zhao, PhD (Author), Jin Zhao, MS (Author), Cheng Chen, MS (Author), Caihong Xu, MS (Author), Wei Su, MS (Author), Yu Pang, PhD (Author), Jun Cheng, MS (Author), Junying Chi, MS (Author), Qian Wang, MS (Author), Yunting Fu, MS (Author), Shitong Huan, MS (Author), Lixia Wang, MS (Author), Dr. Yu Wang, PhD (Author), Daniel P Chin, MD (Author)
• Format: Book
• Published: Elsevier, 2015-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: China has a quarter of all patients with multidrug-resistant tuberculosis (MDRTB) worldwide, but less than 5% are in quality treatment programmes. In a before-and-after study we aimed to assess the effect of a comprehensive programme to provide universal access to diagnosis, treatment, a...